Connect with us

IHOP® Unveils Three New, All-Natural, Black Angus Beef Pancakes (Which Are Actually Burgers)



Reading Time: 4 minutes

One Year after IHOb Campaign Sensation, the Brand Listens to the
Internet and Sticks to What it Knows Best: Pancakes

GLENDALE, Calif.–(BUSINESS WIRE)–Last year, IHOP introduced the award-winning IHOb – for burgers –
advertising campaign and the Internet had a lot to say about it. It told
IHOP to stay in their lane. To stick to pancakes. So, this year, IHOP is
taking the Internet’s advice by calling their new Steakburgers

Launching today, the line-up of all-natural, 100% USDA Choice, Black
Angus beef Pancakes features three new, enticing flavors: The Garlic
Butter “Pancake”, The Loaded Philly “Pancake”, and The Big IHOP
“Pancake”, a “Pancake” with a pancake in it. The Big IHOP Pancake
Burger™ includes a hot, fluffy, cheddar cheese pancake layered between
two juicy beef patties, melted American cheese, crisp bacon and
house-made IHOP sauce, but it’s only available for a limited time. Each
“Pancake” is made with all-natural, 100% USDA choice, Black Angus beef,
smashed on the grill to sear in the juices, hand-seasoned and piled high
with premium ingredients. And, for a limited time, all Pancakes (we mean
Steakburgers) will be served with unlimited fries, starting at $6.99*.

That’s right, IHOP is following up on last year’s successful Ultimate
Steakburger launch with a playful twist that again shows that it takes
its burgers as seriously as it takes it pancakes. After temporarily
changing its name to IHOb – for The International House of Burgers – a
heated debate across social media ensued, with some die-hard pancake
fans taking to Twitter to make it known that they wanted IHOP to “stay
in its lane.” So, this June, the brand is, in fact, sticking to pancakes
by renaming its Ultimate Steakburgers for a limited-time with a line-up
that includes:

  • The Big IHOP Pancake (Burger)™: A world-famous buttermilk
    pancake griddled with Cheddar cheese and layered between two premium
    Steakburger patties, then topped with American cheese, custom-cured
    hickory-smoked bacon and house-made IHOP sauce.
  • Garlic Butter Pancake (Steakburger): Topped with savory
    house-made Gilroy garlic butter, custom-cured hickory-smoked bacon,
    White Cheddar cheese, fresh lettuce, tomato, onion and mayo.
  • Loaded Philly Pancake (Steakburger): Piled high with sautéed
    onions and peppers and smothered with melted White Cheddar cheese and
    Cheddar cheese sauce.

“When we launched our new Ultimate Steakburgers last year, what better
way to show the world that we take our burgers as seriously as we take
our pancakes than by announcing that we’d be changing our name to IHOb …
temporarily,” said Brad Haley, Chief Marketing Officer at IHOP. “That
was hard for a lot of people to accept since they’d always known IHOP
primarily as the breakfast and pancake place, so they took to social
media to tell us – often in no uncertain terms – to stay in our lane and
stick to pancakes. But we made our all-natural, 100% USDA Choice, Black
Angus beef Steakburgers good enough to stand up to the best burgers out
there and we sold a lot of them: initially four times what we sold
before, and they are still selling double what we sold before. So, we’re
listening to the Internet this year by calling our new Steakburgers
‘Pancakes.’ And, so many people asked us why we didn’t have a pancake
burger last year that we’ve even added a ‘Pancake’ with a pancake in it:
The Big IHOP Pancake … Burger.”

In addition to referring to their new burgers as “Pancakes,” IHOP is
taking things a step further by creating a digital experience that aims
to get reluctant burger-lovers onboard with their new approach.

“There were over 3.3 million tweets about #IHOb last year, and some of
them weren’t very nice,” Haley added. “So, our lead creative agency,
Droga5, created a digital experience to engage last year’s naysayers and
convert haters into eaters. Those who tweeted something, shall we say,
unkind last year may find that they’re on The Bancake List, an
aggregated list of Twitter users who tweeted at IHOP to stay in its
lane. Fortunately, there is a way to get off The Bancake List – all they
have to do is tweet something nice about IHOP’s Pancakes/Burgers, and
they’ll be removed from the list. To make it even easier, we’re
providing very funny options people can choose from if they don’t want
to create their own and, best of all, they could even be rewarded with a
token of the brand’s appreciation. Users can visit to
find out whether they or their friends are on The Bancake List, and how
to get off of it. Of course, we’ll also be engaging many of those guests
who were instant fans of our Steakburgers last year.”

The new Steakburger line-up joins IHOP’s original burger flavors,
including The Classic, The Classic with Bacon, Mega Monster, Cowboy BBQ,
The Big Brunch and Jalapeno Kick. Pancakes – the meaty kind or the
fluffy kind — are both best enjoyed with IHOP’s new House-Made
Milkshakes. Recently introduced at all IHOP restaurants, House-Made
Milkshakes are made with hand-scooped, premium, natural vanilla ice
cream, with real milk and whipped topping, and are available in five
craveable flavors: HERSHEY’s Chocolate, Strawberry, OREO® Cookie,
Cold-Brew Coffee and Vanilla.

Guests can visit
to find their nearest IHOP restaurant and learn more about the new
lineup of all-natural, 100% USDA choice Black Angus ‘Pancakes’ and to
see if they are on The Bancake List.

*Price and participation may vary. Offer only available for a limited
time. Dine-in only.

**A select number of rewards will be available. Participating in or
being listed on the Bancake website does not guarantee a prize.

OREO® and the OREO® Wafer Design are trademarks of Mondelez
International group, used under license.

The HERSHEY’S trademark is used under license from The Hershey


For over 60 years, IHOP has been a leader, innovator and expert in all
things breakfast, any time of day. The chain offers 65 different
signature, fresh, made-to-order breakfast options, a wide selection of
popular lunch and dinner items, including Ultimate Steakburgers. IHOP
restaurants offer guests an affordable, everyday dining experience with
warm and friendly service. As of December 31, 2018, there are 1,831 IHOP
restaurants around the world, including restaurants in all 50 states and
the District of Columbia, Puerto Rico and Guam as well as Canada,
Mexico, Guatemala, Panama, Lebanon, the Kingdom of Saudi Arabia, Kuwait,
the United Arab Emirates, Bahrain, Qatar, Thailand and India. IHOP
restaurants are franchised by affiliates of Glendale, Calif.-based Dine
Brands Global, Inc. (NYSE: DIN).


Sami Newman
DeVries Global
+ 1 212-546-8510


Valens expands Exclusive Licence Agreement to Bring Leading Cannabis-Infusion Technology to New International Markets




Valens GroWorks Corp. (TSXV: VGW) (OTCQX: VGWCF) (the “Company” or “Valens“), a cannabinoid-based product company with industry leading extraction, next generation cannabinoid delivery formats and an ISO 17025 accredited analytical lab, is pleased to announce that it has entered an amended manufacturing and sales licence agreement with SōRSE Technology Corporation (“SōRSE“) which grants Valens an exclusive licence for CanadaEuropeAustralia and Mexico to use the proprietary SōRSE emulsion technology (“the Technology“) to produce, market, package, sell and distribute cannabis-infused products (the “Agreement“).

“This Agreement shows Valens’ commitment to invest and broaden its IP portfolio and enable its customers to bring differentiated, next generation products to market,” said Jeff Fallows, President of Valens. “As we move into “Cannabis 2.0” in Canada, we believe the products that offer consistent, high quality and predictable user experiences, like those we are able to create with SōRSE, will capture the lion’s share of attention and be the hallmark for brand development in a strict regulatory environment. With this expanded agreement in place, we have extended this opportunity for our existing customers to key international markets and at the same time established a platform for international consumer brands to add high quality, cannabis infused products to their portfolios.”

The SōRSE Emulsion Technology

The SōRSE emulsion technology transforms cannabis oil into water-soluble forms for use in beverages, edibles, topicals and other consumer products without the burden of cannabis taste, colour or smell. The Technology allows these cannabis infused products to maintain potency when heated, chilled or frozen and provides a number of other key advantages as well, including: (1) a faster observed onset time compared to other infused beverages and edibles, (2) a significant reduction of offset time, (3) an ability to use lower doses of cannabinoids due to the enhanced bioavailability provided by the Technology, and (4) increased consistency and stability with some product formulations achieving more than one-year shelf stability with no evidence of separation.

“We are proud to expand our partnership with Valens and leverage their near-term access to various global markets,” says Howard Lee, CEO of SōRSE. “Over the last year, our team of more than 40 plus professionals has continued to actively focus on creating and developing innovative, desirable products and formats of consumption for cannabis consumers. As emulsion technology becomes more popular through new delivery methods such as ingestion, transdermal, topical and more, it is imperative that quality and safety in consumption leads all innovation in this sector. This is a shared value and mandate that our teams at SōRSE and Valens both prioritize. We look forward to continuing this working relationship with Valens and introducing our award-winning emulsion technology to the global markets.”

Geographic Expansion

The Agreement grants Valens an exclusive licence to use the Technology in CanadaEuropeAustralia and Mexico (except in respect of medical applications requiring clinical trials) during the initial 5-year term, subject to certain performance milestones. This increases the addressable market from 37 million in the current Canada only agreement to 700 million people in the new Agreement, an increase of almost 20x. Furthermore, the Agreement provides a framework for Valens to obtain rights to establish non-exclusive agreements to sell cannabis-infused products using the Technology in the U.S. market and other markets, globally.

Bolstering “Cannabis 2.0” Platform

With the expanded exclusivity, Valens and its white label clients are positioned to not only succeed in the Canadian market, but also in the rapidly emerging legal cannabis and hemp-derived CBD markets in EuropeAustraliaMexico and beyond. The Agreement adds to the Company’s leading white label product offerings across numerous “Cannabis 2.0” categories such as beverages, edibles, transdermal products and more, enabling Valens to better serve its current and future partners.

“We have seen incredible interest from our current and potential clients regarding the SōRSE emulsion technology and we are thrilled to finalize the expanded licence agreement with SōRSE,” said Tyler Robson, CEO of Valens. “We expect the expanded exclusive territory will provide our clients with improved visibility and greater opportunity as they look to build global businesses around cannabis-infused products over the long term.

This is an exciting time in the evolution of ingestible cannabis products such as beverages and edibles. Historically, ingestible products have been lacking the necessary technology to provide a consistent, predictable experience, ultimately giving little reason to consume in this manner. At Valens, we expect that properly formulated, extract-based cannabis products, and infused beverages in particular, could disrupt many established beverage categories such as soft drinks, sports drinks, value-added water and alcohol, the latter of which has a monthly spend per capita that is roughly 16 times higher compared to legal cannabis spend in Canada. We believe the ability to plan an occasion and predict the outcome of use will be a game changer in the market and be the catalyst to bring about the full market potential of cannabis infused beverages and edibles, globally.”

Future White Label Services

The Agreement furthers the existing relationship between Valens and SōRSE and enables Valens to produce and sell SōRSE’s portfolio of branded products in Canada and the other exclusive markets at the option of the Company. These branded products include Happy Apple, a cannabis-infused sparkling cider and Major, a cannabis-infused fruit drink, both recognized as top selling cannabis beverages in the State of Washington, Pearl20, a cannabis-infused food and beverage mixer, and the Utopia line of cannabis-infused sparkling water, among others.

Agreement Summary

The consideration at closing for the exclusivity in the expanded geography was US$10 million, comprised of US$6 million in cash and US$4 million to be issued in common shares of the Company (the “Common Shares“). The Agreement carries an initial 5-year exclusive term with a 2-year renewal of the exclusivity, subject to certain performance milestones related to operational and financial achievements (the “Milestones“). As part of the Agreement, Valens will transfer to SōRSE royalty payments calculated as a percentage of sales (the “Royalty Payments“) and the Royalty Payments will be subject to an annual minimum of $2 million over the 5-year term. The Agreement also provides for a continuation of the Agreement on a non-exclusive basis after the 2-year renewal, subject to annual minimum royalty payments.

All Common Shares pursuant to the Agreement were issued at an indicative price of CDN$3.0471, being the volume-weighted average price of the Common Shares on the TSX Venture Exchange (“TSXV“) for the ten (10) trading days ending December 9, 2019. The Agreement remains subject to approval from the TSXV. All Common Shares issued in connection with the Agreement will be subject to a restricted period of four months and one day. There are no finders’ fees payable by the Company in connection with the Agreement.


SOURCE Valens GroWorks Corp.

Continue Reading


Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Energy Transfer LP, Grubhub, Aurora Cannabis, and The RealReal and Encourages Investors to Contact the Firm




Bragar Eagel & Squire, P.C., a nationally recognized shareholder law firm, reminds investors that class action lawsuits have been commenced on behalf of stockholders of  Energy Transfer LP (NYSE: ET), Grubhub, Inc. (NYSE: GRUB), Aurora Cannabis, Inc. (NYSE: ACB), and The RealReal, Inc. (NASDAQ: REAL). Stockholders have until the deadlines below to petition the court to serve as lead plaintiff. Additional information about each case can be found at the link provided.

Energy Transfer LP (NYSE: ET)

Class Period: February 25, 2017 to November 11, 2019

Lead Plaintiff Deadline: January 20, 2020

On November 12, 2019, the Associated Press reported that Energy Transfer’s Mariner East pipeline project was under investigation by the Federal Bureau of Investigation (“FBI”). Citing interviews with current and former state employees, the Associated Press reported that the FBI’s investigation “involves the permitting of the pipeline, whether [Pennsylvania Governor Tom] Wolf and his administration forced environmental protection staff to approve construction permits and whether Wolf or his administration received anything in return.”

On this news, Energy Transfer’s stock price fell $0.81 per share, or 6.77%, over the following two trading sessions, closing at $11.16 per share on November 13, 2019.

The complaint, filed on November 20, 2019, alleges that throughout the Class Period, defendants made materially false and/or misleading statements, as well as failed to disclose material adverse facts about the company’s business, operational and compliance policies. Specifically, defendants made false and/or misleading statements and/or failed to disclose that: (i) Energy Transfer’s permits to conduct the Mariner East pipeline project in Pennsylvania were secured via bribery and/or other improper conduct; (ii) the foregoing misconduct increased the risk that the Company and/or certain of its employees would be subject to government and/or regulatory action; and (iii) as a result, the Company’s public statements were materially false and misleading at all relevant times.


SOURCE Bragar Eagel & Squire, P.C.

Continue Reading


iX Biopharma secures Australian cannabis manufacture licence




Specialty pharmaceutical company iX Biopharma Ltd (SGX:42C) (“iX Biopharma” or, together with its subsidiaries, “the Group”) is pleased to announce today that its wholly-owned subsidiary, iX Syrinx (“Syrinx”), has been awarded a cannabis manufacture license from the Australian Office of Drug Control under the Narcotics Drugs Act 1967. Under the said licence, the Group is permitted to manufacture and supply extracts and tinctures of cannabis and cannabis resins.

This marks a significant milestone for the Group. Syrinx operates a TGA cGMP certified facility and holds import and export licences for cannabis and State poisons licences; together with the newly granted cannabis manufacture licence, the Group is now able to fully participate in the global medicinal cannabis business.

Importantly, the Group will be able to manufacture and distribute its newly formulated Xativa™ sublingual cannabis wafers in Australia through the Australian Special Access Scheme and in overseas markets. Xativa™ leverages on iX Biopharma’s novel and patented WaferiX™ technology to improve the speed and level of absorption and predictability of effect of medicinal cannabis. Xativa™ provides patients with a more elegant and discreet way to consume medicinal cannabis compared to existing dosage forms for cannabis such as joints, vapes and tinctures, and hence offers a superior user experience. The Group has received feedback from physicians in Australia that the advantages of Xativa™ and its differentiation from the rest of the market offerings are clear and highly desired.

Produced via iX Biopharma’s proprietary freeze-drying technique, the porous and amorphous WaferiX™ matrix holding the active CBD molecules is designed to collapse quickly within the sublingual space. The actives are then transported rapidly across the sublingual membrane into the blood vessels for a rapid onset of action.

“Globally, the use of cannabis for the treatment of a wide range of medical conditions has been growing at an exponential pace. The grant of the cannabis manufacturing licence has come at a most opportune time, allowing us to manufacture, distribute and promote Xativa™ as the gold standard in medicinal cannabis delivery, thereby charting a new growth trajectory for the Group,” said Ms Eva Tan, Director of Corporate and Commercial Strategy of iX Biopharma.


SOURCE iX Biopharma Ltd

Continue Reading

Trending Online

Grassnews is a news publishing website which digests / hand picks the latest news about the cannabis industry, and serves them to you daily.

Contact us:

© 2019 - part of PICANTE Media. All rights reserved. Registered in Romania under Proshirt SRL, Company number: 2134306, EU VAT ID: RO21343605. Office address: Blvd. 1 Decembrie 1918 nr.5, Targu Mures, Romania